Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease rheumatoid arthritis
Symptom C0042373|vascular disease
Sentences 64
PubMedID- 20735865 Palomino-morales and colleagues 1 report the novel observation that a common polymorphism in the gene for methylene tetrahydrofolate reductase (mthfr) that markedly reduces enzyme activity (by as much as 65% in homozygotes) may predispose to the development of atherosclerotic cardiovascular disease (ascvd) in patients with rheumatoid arthritis (ra).
PubMedID- 26082375 Pathophysiologic mechanisms and risk management of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 23244227 Cardiovascular diseases in patients with rheumatoid arthritis.
PubMedID- 21345288 Lack of association between retn rs1862513 polymorphism and cardiovascular disease in rheumatoid arthritis patients.
PubMedID- 23204310 Atherosclerosis and cardiovascular disease in rheumatoid arthritis.
PubMedID- 24585741 Objective: despite numerous studies reporting increased cardiovascular disease (cvd) in patients with rheumatoid arthritis (ra), the impact of ra on managing modifiable cvd risk factors remains understudied.
PubMedID- 20842919 Cardiovascular diseases in rheumatoid arthritis.
PubMedID- 22284683 We also suggest strategies for risk stratification and treatment of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 24874661 Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis.
PubMedID- 22337246 Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 20827876 Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions.
PubMedID- 21981268 Lack of association of il6r rs2228145 and il6st/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 23193471 Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america.
PubMedID- 21109513 Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives.
PubMedID- 20040642 Risk factors for cardiovascular disease in rheumatoid arthritis: defining treatment thresholds.
PubMedID- 26362702 Objective: to identify risk factors for cardiovascular disease in patients with rheumatoid arthritis (ra).
PubMedID- 21846359 Ccr5delta32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study.
PubMedID- 24511540 For instance, angiopoietin-2 (angpt-2), a marker of endothelial cell activation, has been proposed as a mediator of angiogenesis, which might play an important role in the regulation of endothelial integrity and inflammation and thus is related to severity and cardiovascular disease in patients with rheumatoid arthritis 2.
PubMedID- 24458537 The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients.
PubMedID- 21385539 Lack of association between lep rs2167270 (19 g>a) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 21905005 Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events.
PubMedID- 24498229 Conclusion: in observational studies the finding of incident cardiovascular disease in patients with rheumatoid arthritis exposed to glucocorticoids is strongly confounded by indication due to high disease activity.
PubMedID- 23584985 Novel risk factors for cardiovascular disease in rheumatoid arthritis.
PubMedID- 21420089 Tnfa -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 22161801 Results of prior studies have suggested that methotrexate (mtx) may improve vascular disease in patients with psoriasis and rheumatoid arthritis.
PubMedID- 21520672 Excess mortality from cardiovascular disease in patients with rheumatoid arthritis--nsaid a possible cause.
PubMedID- 22249350 Risk factors for cardiovascular disease in rheumatoid arthritis.
PubMedID- 21073447 Lack of association between adipoq rs266729 and adipoq rs1501299 polymorphisms and cardiovascular disease in rheumatoid arthritis patients.
PubMedID- 20638217 Objective: this paper describes the rationale and design of a theory-informed patient education programme addressing cardiovascular disease for people with rheumatoid arthritis (ra) to illustrate how theory can explicitly be translated into practice.
PubMedID- 20868308 Objectives: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd).
PubMedID- 24268008 Cardiovascular disease in rheumatoid arthritis.
PubMedID- 22935383 Objectives: the impact of metabolic risk factors on atherosclerotic cardiovascular disease (acvd) in patients with rheumatoid arthritis (ra) from developing populations is currently unknown.
PubMedID- 21071477 Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.
PubMedID- 21269581 Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 23079082 Introduction: recent studies revealed that co-morbidity and mortality due to cardiovascular disease are increased in patients with rheumatoid arthritis (ra) but little is known about factors involved in these manifestations.
PubMedID- 24498997 Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 21388351 Vascular endothelial growth factor a and cardiovascular disease in rheumatoid arthritis patients.
PubMedID- 23983474 The effects of the il-6r and il-6st/gp130 genes on the risk for cardiovascular disease in patients with rheumatoid arthritis were assessed in patients with rheumatoid arthritis who were genotyped for the functional gene polymorphisms.
PubMedID- 23666917 Objective: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd), but little is known about its association with another form of vascular disorder, venous thromboembolism (vte).
PubMedID- 21180241 Platelet histogram indices and cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 21411091 Prediction of genetic risk for cardiovascular disease in patients with rheumatoid arthritis: present and promises.
PubMedID- 22521305 Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 23818136 Objective: to determine whether the impact of aging on cardiovascular disease (cvd) risk in patients with rheumatoid arthritis (ra) differs from that in the general population (as estimated by the framingham risk score frs).
PubMedID- 26117596 Prevention of cardiovascular disease in rheumatoid arthritis.
PubMedID- 24361194 Usefulness of the ankle-brachial index as a survey method for subclinical vascular disease in patients with rheumatoid arthritis.
PubMedID- 22513132 The excess risk of cardiovascular disease (cvd) associated with rheumatoid arthritis (ra) has long been recognized .
PubMedID- 22808986 Different techniques have proven to be useful in determining the presence of subclinical cardiovascular disease in patients with rheumatoid arthritis (ra).
PubMedID- 21608334 Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.
PubMedID- 23899926 Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 22337612 Apolipoprotein b-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis.

Page: 1 2